KeyGene Licenses Technology to LGC, Bayer

 

NEW YORK  – Dutch ag-bio company KeyGene announced today that it has licensed its proprietary sequence-based genotyping technology to LGC and Bayer’s Crop Science division.

Under the terms of the separate agreements, KeyGene has given Bayer a non-exclusive license for the in-house use of the SBG technology for crop improvement, and has given LGC a non-exclusive license for the commercial offering and use of SBG technology across all species, including field and vegetable crops, for the global market, the company said in a statement.

Subscribe to get the latest news